188 related articles for article (PubMed ID: 22315049)
1. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Rohrmann S; Grote VA; Becker S; Rinaldi S; Tjønneland A; Roswall N; Grønbæk H; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Teucher B; Boeing H; Drogan D; Dilis V; Lagiou P; Trichopoulou A; Palli D; Tagliabue G; Tumino R; Vineis P; Mattiello A; Rodríguez L; Duell EJ; Molina-Montes E; Dorronsoro M; Huerta JM; Ardanaz E; Jeurnink S; Peeters PH; Lindkvist B; Johansen D; Sund M; Ye W; Khaw KT; Wareham NJ; Allen NE; Crowe FL; Fedirko V; Jenab M; Michaud DS; Norat T; Riboli E; Bueno-de-Mesquita HB; Kaaks R
Br J Cancer; 2012 Feb; 106(5):1004-10. PubMed ID: 22315049
[TBL] [Abstract][Full Text] [Related]
2. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.
Allen NE; Key TJ; Appleby PN; Travis RC; Roddam AW; Rinaldi S; Egevad L; Rohrmann S; Linseisen J; Pischon T; Boeing H; Johnsen NF; Tjønneland A; Grønbaek H; Overvad K; Kiemeney L; Bueno-de-Mesquita HB; Bingham S; Khaw KT; Tumino R; Berrino F; Mattiello A; Sacerdote C; Palli D; Quirós JR; Ardanaz E; Navarro C; Larrañaga N; Gonzalez C; Sanchez MJ; Trichopoulou A; Travezea C; Trichopoulos D; Jenab M; Ferrari P; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1121-7. PubMed ID: 17548673
[TBL] [Abstract][Full Text] [Related]
4. IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).
Rinaldi S; Peeters PH; Berrino F; Dossus L; Biessy C; Olsen A; Tjonneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Téhard B; Nagel G; Linseisen J; Boeing H; Lahmann PH; Trichopoulou A; Trichopoulos D; Koliva M; Palli D; Panico S; Tumino R; Sacerdote C; van Gils CH; van Noord P; Grobbee DE; Bueno-de-Mesquita HB; Gonzalez CA; Agudo A; Chirlaque MD; Barricarte A; Larrañaga N; Quiros JR; Bingham S; Khaw KT; Key T; Allen NE; Lukanova A; Slimani N; Saracci R; Riboli E; Kaaks R
Endocr Relat Cancer; 2006 Jun; 13(2):593-605. PubMed ID: 16728585
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers.
Stolzenberg-Solomon RZ; Limburg P; Pollak M; Taylor PR; Virtamo J; Albanes D
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):438-44. PubMed ID: 15006921
[TBL] [Abstract][Full Text] [Related]
6. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
Peeters PH; Lukanova A; Allen N; Berrino F; Key T; Dossus L; Rinaldi S; van Gils CH; Bueno-de-Mesquita HB; Boeing H; Schulz M; Chang-Claude J; Linseisen J; Panico S; Sacerdote C; Palli D; Tumino R; Trichopoulou A; Trichopolos D; Bamia C; Larranaga N; Ardanaz E; Pera G; Quirós JR; Martínez-García C; Navarro C; Bingham SA; Khaw KT; Clavel F; Tjonneland A; Olsen A; Overvad K; Tetsche MS; Lund E; Lundin E; Berglund G; Riboli E; Kaaks R
Endocr Relat Cancer; 2007 Mar; 14(1):81-90. PubMed ID: 17395977
[TBL] [Abstract][Full Text] [Related]
7. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Br J Cancer; 2007 Jul; 97(1):98-104. PubMed ID: 17533398
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death.
Lin Y; Tamakoshi A; Kikuchi S; Yagyu K; Obata Y; Ishibashi T; Kawamura T; Inaba Y; Kurosawa M; Motohashi Y; Ohno Y
Int J Cancer; 2004 Jul; 110(4):584-8. PubMed ID: 15122592
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Relation to the Risk of Type 2 Diabetes Mellitus: Results From the EPIC-Potsdam Study.
Drogan D; Schulze MB; Boeing H; Pischon T
Am J Epidemiol; 2016 Mar; 183(6):553-60. PubMed ID: 26880678
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
[TBL] [Abstract][Full Text] [Related]
13. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women.
Norat T; Dossus L; Rinaldi S; Overvad K; Grønbaek H; Tjønneland A; Olsen A; Clavel-Chapelon F; Boutron-Ruault MC; Boeing H; Lahmann PH; Linseisen J; Nagel G; Trichopoulou A; Trichopoulos D; Kalapothaki V; Sieri S; Palli D; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Agudo A; Amiano P; Ardanoz E; Martinez C; Quirós R; Tormo MJ; Bingham S; Key TJ; Allen NE; Ferrari P; Slimani N; Riboli E; Kaaks R
Eur J Clin Nutr; 2007 Jan; 61(1):91-8. PubMed ID: 16900085
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Crowe FL; Key TJ; Allen NE; Appleby PN; Overvad K; Grønbæk H; Tjønneland A; Halkjær J; Dossus L; Boeing H; Kröger J; Trichopoulou A; Zylis D; Trichopoulos D; Boutron-Ruault MC; de Lauzon-Guillain B; Clavel-Chapelon F; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Gram IT; Rodríguez L; Jakszyn P; Molina-Montes E; Navarro C; Barricarte A; Larrañaga N; Khaw KT; Rodwell S; Rinaldi S; Slimani N; Norat T; Gallo V; Riboli E; Kaaks R
Ann Hum Biol; 2011 Mar; 38(2):194-202. PubMed ID: 20731527
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China.
London SJ; Yuan JM; Travlos GS; Gao YT; Wilson RE; Ross RK; Yu MC
J Natl Cancer Inst; 2002 May; 94(10):749-54. PubMed ID: 12011225
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of IGF-I and IGFBP-3 and brain tumor risk in the European Prospective Investigation into Cancer and Nutrition.
Rohrmann S; Linseisen J; Becker S; Allen N; Schlehofer B; Overvad K; Olsen A; Tjønneland A; Melin BS; Lund E; Vineis P; Grioni S; Tumino R; Palli D; Mattiello A; Bonet C; Chirlaque MD; Sánchez MJ; Rodríguez L; Dorronsoro M; Ardanaz E; Lagiou P; Trichopoulou A; Trichopoulos D; Dossus L; Grote VA; Boeing H; Aleksandrova K; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Khaw KT; Wareham NJ; Key TJ; Rinaldi S; Romieux I; Gallo V; Michaud DS; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2174-82. PubMed ID: 21788435
[TBL] [Abstract][Full Text] [Related]
17. Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era.
Platz EA; Pollak MN; Leitzmann MF; Stampfer MJ; Willett WC; Giovannucci E
Cancer Causes Control; 2005 Apr; 16(3):255-62. PubMed ID: 15947877
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk.
Allen NE; Roddam AW; Allen DS; Fentiman IS; Dos Santos Silva I; Peto J; Holly JM; Key TJ
Br J Cancer; 2005 Apr; 92(7):1283-7. PubMed ID: 15756268
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: A nested case-control study in large scale cohort study in Japan.
Mikami K; Ozasa K; Nakao M; Miki T; Hayashi K; Watanabe Y; Mori M; Sakauchi F; Washio M; Kubo T; Suzuki K; Wakai K; Nakachi K; Tajima K; Ito Y; Inaba Y; Tamakoshi A;
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():57-61. PubMed ID: 20553083
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
